Brief: Newbury Pharma Enters Partnership To Commercialize Registered Products
Oct 6 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* NEWBURY PHARMACEUTICALS HAS ENTERED INTO A PARTNERSHIP
GRANTING
ACCESS TO 6 REGISTERED PRODUCTS
* NEWBURY AND AMAROX WILL SEEK TO COMMERCIALIZE CERTAIN
REGISTERED
PRODUCTS DURING 2024 WITH AMBITION TO EXPAND PORTFOLIO WITH MORE
PRODUCTS
Source text for Eikon: ID:nMFN8R4PCL
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln